FDA Inspection 719267 — Dr. Andre Vertruyen
The FDA completed an inspection of Dr. Andre Vertruyen on April 7, 2011 in Antwerp. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 7, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Antwerp (Belgium)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7545 | 21 CFR 312.120(c) | Foreign clinical trials |